2-hour postchallenge serum glucose measures
and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study. Arch Intern Med 2002;162:209-16.
74. Banerjee C, Moon YP, Paik MC, Rundek T, Mora-McLaughlin C,
Vieira JR, et al. Duration of diabetes and risk of ischemic stroke: the
Northern Manhattan Study. Stroke 2012;43:1212-7.
75. Zhang C, Zhou YH, Xu CL, Chi FL, Ju HN. Efﬁcacy of intensive control
of glucose in stroke prevention: a meta-analysis of data from 59,197
participants in 9 randomized controlled trials. PLoS One 2013;8:
e54465.
76. Laakso M. Beneﬁts of strict glucose and blood pressure control in
type 2 diabetes: lessons from the UK Prospective Diabetes Study.
Circulation 1999;99:461-2.
77. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB,
et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl
J Med 2008;358:2545-59.
78. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M,
et al. Intensive blood glucose control and vascular outcomes in
patients with type 2 diabetes. N Engl J Med 2008;358:2560-72.
79. Iso H, Jacobs DR Jr, Wentworth D, Neaton JD, Cohen JD. Serum
cholesterol levels and six-year mortality from stroke in 350,977 men
screened for the multiple risk factor intervention trial. N Engl J Med
1989;320:904-10.
80. Bots ML, Elwood PC, Nikitin Y, Salonen JT, Freire de
Concalves A, Inzitari D, et al. Total and HDL cholesterol and risk
of stroke. EUROSTROKE: a